The American Association for Cancer Research (AACR) has proudly revealed the distinguished recipients of the 2026 AACR June L. Biedler Prize for Cancer Journalism. This prestigious award celebrates outstanding contributions in cancer reporting that enhance public understanding of cancer research, treatments, and the realities experienced by patients worldwide. Honoring exemplary excellence across multiple media platforms—including magazines, newspapers, online multimedia, and broadcast—the prize highlights journalists who navigate intricate scientific landscapes to deliver clear, compelling narratives that make groundbreaking cancer science accessible to broad audiences.
Laurie Abraham, a freelance journalist and editor affiliated with New York Magazine, secured the award in the magazine category for her essay “My Colon.” Abraham’s deeply personal account skillfully juxtaposes raw, candid reflections on her colorectal cancer diagnosis with an informative dive into current research and therapeutic approaches. Her narrative transcends mere memoir: it ventures into the realm of public education, demystifying a cancer type often shrouded in stigma and silence. By translating highly technical medical language into approachable content while maintaining emotional authenticity, Abraham bridges the gap between scientific complexity and public engagement.
In the newspaper category, Carolyn Johnson of The Washington Post earned acclaim for her investigative piece “NIH scientists have a cancer breakthrough. Layoffs are delaying it.” This article weaves the interdependent stories of scientific progress and institutional challenges faced by the National Institutes of Health (NIH). Johnson delves into novel research regarding tumor-infiltrating lymphocyte (TIL) therapy aimed at solid tumors, chronicling the evolution of cell-based immunotherapy and emphasizing its potential to transform cancer treatment paradigms. Crucially, the article reveals how staffing reductions at NIH are delaying promising clinical trials, offering a poignant commentary on the intersection of scientific innovation, bureaucratic dynamics, and patient hope.
The online/multimedia award went to Bloomberg News journalists Robert Langreth, Tanaz Meghjani, and Anna Edney for their revealing three-part series entitled “Cancer Capitalism.” This incisive investigation exposes the harsh realities behind the rising costs of cancer therapeutics. Gleaning insights from extensive data analysis and patient experiences, the series critiques the profit-driven forces shaping oncology care. It highlights cases of expensive pharmaceuticals that reach astronomical price points, issues surrounding medical devices with unforeseen failures, and the potential of dose optimization to broaden treatment accessibility. By unpacking economic undercurrents that often remain invisible in public discourse, this series fuels critical conversations about equity and sustainability in cancer care.
Jes Burns and Brooke Herbert, producers for Oregon Public Broadcasting’s program All Science. No Fiction., earned recognition in the television/radio/podcast category for their innovative report, “Researchers in Oregon aim to slow down cancer by remotely cooking tumors.” This visually engaging story tackles emerging nanotechnology-based approaches designed to arrest tumor growth through targeted thermal ablation. Their accessible presentation demystifies complex scientific concepts behind nanoparticle-mediated hyperthermia, underscoring its promising applications in ovarian cancer and endometriosis treatment. Through deft storytelling and interactive graphics, Burns and Herbert illuminate cutting-edge science while maintaining a balanced tone that invites insight and further inquiry.
Another compelling entry in the broadcast category was “Diagnosis Young: The New Face of Cancer in NC,” a poignant documentary by Cristin Severance and Dwayne Myers for WRAL in Raleigh, North Carolina. This powerful film surveys the startling rise in cancer diagnoses among younger populations—a demographic traditionally considered low-risk. Through intimate interviews with patients, caregivers, and clinical experts, the documentary elucidates the multifaceted challenges young cancer patients face, from disrupted life trajectories to emotional and logistical hurdles related to treatment. By confronting outdated epidemiological assumptions, Severance and Myers provide critical insights into shifting cancer incidence patterns, emphasizing the urgency for tailored public health interventions.
The AACR June L. Biedler Prize, named after pioneering cancer researcher June L. Biedler, PhD, was established to foster excellence in cancer journalism, recognizing professionals whose work not only informs but also inspires public awareness and advocacy. Since its inception in 2015, the prize has underscored the indispensable role journalism plays in translating complex oncology research into vivid stories that touch lives and shape policy. The 2026 laureates exemplify this mission, demonstrating a profound commitment to rigorous reporting, scientific literacy, and empathetic storytelling.
Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, emphasized the significance of this year’s winners. She praised their ability to distill complex scientific concepts into clear, accessible narratives while weaving compelling human stories that resonate widely. Foti highlighted how their reporting significantly enriches public understanding of cancer, underscoring the prize’s role in recognizing and amplifying invaluable journalistic contributions fueled by Dr. Biedler’s generous bequest.
Clifton Leaf, chair of the Biedler Prize and adjunct professor at Columbia Journalism School, echoed these sentiments, noting the inherent complexity of cancer science, drug development, treatment, and survivorship. He applauded the awardees for their exceptional clarity and insight, qualities essential for great science communication. Leaf remarked that this year’s entries brought profound understanding to myriad challenging topics, fulfilling the core objectives of effective cancer journalism.
Central to the winning stories is the ability to contextualize evolving cancer science within the broader societal and policy landscapes. Whether it is the tension between innovative therapies and bureaucratic obstacles, economic pressures influencing drug accessibility, or demographic shifts reshaping cancer’s impact, these journalistic works offer nuanced perspectives that move beyond superficial coverage. This depth aids both lay and professional audiences in grappling with the intricate realities of cancer research and care.
Moreover, the recipients excel at humanizing the scientific enterprise, melding technical explanations with personal narratives. This approach anchors abstract concepts in lived experience, facilitating empathy and engagement. By doing so, the storytellers foster a connection between scientific breakthroughs and their direct implications on patients and families, elevating public discourse and potentially influencing health outcomes.
Technological innovation also emerged as a recurring theme, reflected in explorations of nanomedicine, immune therapies, and data-driven analyses of treatment efficacy and cost. These narratives bridge bench science with bedside realities, illustrating the dynamic continuum of cancer research. As cancer treatment evolves rapidly, such informed journalism becomes critical in navigating the uncertainties and opportunities that arise within this fast-moving field.
The award ceremony, scheduled for Sunday, April 19, during the AACR Annual Meeting 2026 in San Diego, California, will offer an occasion to celebrate these achievements among an international assembly of researchers, clinicians, patients, and advocates. The event underscores the collaborative spirit extending from laboratory discovery through journalistic dissemination to patient empowerment.
In essence, the 2026 AACR June L. Biedler Prize winners embody the highest standards of cancer journalism—conveying scientific rigor, ethical responsibility, and narrative excellence. Their work forms a vital conduit between the cancer research community and the public, fostering informed dialogue, enhancing awareness, and ultimately contributing to the global effort to understand and defeat cancer.
—
Subject of Research: Cancer research, including colorectal cancer, immunotherapy (TIL therapy), cancer treatment economics, nanotechnology-based tumor ablation, and cancer epidemiology among young adults.
Article Title: 2026 AACR June L. Biedler Prize for Cancer Journalism Award Winners Announced
News Publication Date: April 2026
Web References:
- American Association for Cancer Research (AACR) Annual Meeting 2026: https://www.aacr.org/meeting/aacr-annual-meeting-2026/
- June L. Biedler Prize for Cancer Journalism: https://www.aacr.org/about-the-aacr/newsroom/the-aacr-june-l-biedler-prize-for-cancer-journalism/
Image Credits: All photos provided by the AACR archives, accessible at their respective linked sources.
Keywords: Cancer journalism, colorectal cancer, tumor-infiltrating lymphocyte therapy, immunotherapy, cancer treatment costs, nanotechnology, cancer epidemiology, science communication, cancer research reporting, AACR June L. Biedler Prize
